Kura Oncology Future Growth
Future criteria checks 2/6
Kura Oncology is forecast to grow earnings and revenue by 27.8% and 66.8% per annum respectively while EPS is expected to grow by 31.7% per annum.
Key information
27.8%
Earnings growth rate
31.7%
EPS growth rate
Biotechs earnings growth | 35.1% |
Revenue growth rate | 66.8% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 01 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 103 | -201 | -189 | -188 | 10 |
12/31/2025 | 9 | -237 | -197 | -196 | 12 |
12/31/2024 | N/A | -212 | -168 | -183 | 12 |
6/30/2024 | N/A | -182 | -155 | -155 | N/A |
3/31/2024 | N/A | -168 | -138 | -138 | N/A |
12/31/2023 | N/A | -153 | -125 | -125 | N/A |
9/30/2023 | N/A | -143 | -117 | -117 | N/A |
6/30/2023 | N/A | -140 | -110 | -109 | N/A |
3/31/2023 | N/A | -137 | -114 | -114 | N/A |
12/31/2022 | N/A | -136 | -111 | -110 | N/A |
9/30/2022 | N/A | -135 | -108 | -107 | N/A |
6/30/2022 | N/A | -133 | -112 | -110 | N/A |
3/31/2022 | N/A | -132 | -109 | -108 | N/A |
12/31/2021 | N/A | -130 | -106 | -105 | N/A |
9/30/2021 | N/A | -124 | -101 | -99 | N/A |
6/30/2021 | N/A | -114 | -93 | -92 | N/A |
3/31/2021 | N/A | -101 | -80 | -79 | N/A |
12/31/2020 | N/A | -90 | -72 | -70 | N/A |
9/30/2020 | N/A | -81 | -67 | -65 | N/A |
6/30/2020 | N/A | -74 | -62 | -61 | N/A |
3/31/2020 | N/A | -68 | -61 | -60 | N/A |
12/31/2019 | N/A | -63 | -55 | -55 | N/A |
9/30/2019 | N/A | -61 | -51 | -51 | N/A |
6/30/2019 | N/A | -60 | -52 | -52 | N/A |
3/31/2019 | N/A | -60 | -50 | -50 | N/A |
12/31/2018 | N/A | -60 | -49 | -49 | N/A |
9/30/2018 | N/A | -55 | -46 | -46 | N/A |
6/30/2018 | N/A | -49 | -39 | -39 | N/A |
3/31/2018 | N/A | -43 | N/A | -33 | N/A |
12/31/2017 | N/A | -35 | N/A | -28 | N/A |
9/30/2017 | N/A | -32 | N/A | -28 | N/A |
6/30/2017 | N/A | -30 | N/A | -27 | N/A |
3/31/2017 | N/A | -28 | N/A | -27 | N/A |
12/31/2016 | N/A | -28 | N/A | -25 | N/A |
9/30/2016 | N/A | -27 | N/A | -24 | N/A |
6/30/2016 | N/A | -26 | N/A | -23 | N/A |
3/31/2016 | N/A | -25 | N/A | -21 | N/A |
12/31/2015 | N/A | -23 | N/A | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KUR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KUR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KUR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KUR's revenue (66.8% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: KUR's revenue (66.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KUR's Return on Equity is forecast to be high in 3 years time